Gene symbol and protein | Gene Location | All allelic disease phenotypes - locus/disease symbols |
B3GALNT2Beta-1,3-N-acetylgalacto-saminyltransferase 2     | 1q42.3 | * Congenital muscular dystrophy with hypoglycosylation of dystroglycan WWWS/MEB li - MDDGA11 (2.29)
|
B4GALNT1Beta-1,4-N-acetyl-galactosaminyl transferase 1      | 12q13.3 | * Spastic paraplegia 26 - SPG26 (14.100, 15.36) * Charcot-Marie-Tooth disease, axonal - (14.100, 15.36)
|
B4GAT1UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyl-transferase 1    | 11q13.2 | * Walker-Warburg syndrome (WWS) - MDDGA13 (2.31)
|
BAG3BCL2-associated athanogene 3     | 10q25.2-q26.2 | * myofibrillar myopathy with bag3 defect - (5.7, 10.71, 14.75)
* Dilated cardiomyopathy related to BAG3 - CMD1HH (5.7, 10.71, 14.75) * Charcot-Marie-Tooth disease, axonal, related to BAG3 - (5.7, 10.71, 14.75)
|
| 14q32.33 | * Dilated cardiomyopathy, 2F - CMD2F (10.86)
|
BEAN1Brain expressed, associated with Nedd42      | 16q21 | * spinocerebellar ataxia-31 - SCA31 (13.28)
|
BICD2Bicaudal D homolog 2 (Drosophila)     | 9q22.31 | * Spinal muscular atrophy, lower extremity, autosomal dominant 2 - SMALED2A (12.42, 12.43, 17.24)
* Spinal muscular atrophy, lower extremity-predominant, autosomal dominant 2B - SMALED2B (12.42, 12.43, 17.24) * Arthrogryposis and BICD2-related neuromuscular disease - (12.42, 12.43, 17.24)
|
| 2q14 | * Centronuclear myopathy 2 - CNM2 (3.19)
|
| 11q12-q13.5 | * Spastic paraplegia 17 - SPG17 (12.35, 15.9)
* Neuronopathy, distal hereditary motor, autosomal dominant 13 - HMND13 (12.35, 15.9)
|
BVESBlood vessel epicardial substance     | 6q21 | * Limb-Girdle, Muscular dystrophy, type 2X - LGMD2X (1.38)
|